Inventor profile of:

Nils Morgenthaler

City:

Berlin

Country:

Germany

Published Applications:

20

Last publication date:

2017-03-02

Top Assignees for applications by Nils Morgenthaler

The entities that hold a legal rights for patent applications filed by inventor Morgenthaler Nils:

Recent patent applications by Morgenthaler Nils

Nils Morgenthaler from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-03-02
US20170059583A1
Physics

Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II

#2 | 2016-06-16
US20160169912A1
Physics

Diagnosis and Risk Assessment of Pancreatic Diabetes Using MR-proADM

#3 | 2016-05-12
US20160131660A1
Physics

In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient

#4 | 2015-07-09
US20150192595A1
Physics

METHODS OF DIAGNOSIS AND RISK STRATIFICATION OF ADVERSE EVENTS IN POST MYOCARDIAL INFARCTION PATIENTS USING PRO-ADRENOMEDULLIN

#5 | 2014-01-16
US20140017808A1
Physics

Prognosis and risk assessment in stroke patients by determining the level of marker peptides

#6 | 2013-12-26
US20130344513A1
Physics

Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II

#7 | 2012-10-25
US20120270245A1
Physics

DIAGNOSIS AND RISK STRATIFICATION OF INFECTIONS AND CHRONIC DISEASES OF THE RESPIRATORY TRACT AND LUNGS BY MEANS OF PROVASOPRESSIN, PARTICULARLY COPEPTIN OR NEUROPHYSIN II

#8 | 2011-10-27
US20110263821A1
Physics

PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES

#9 | 2011-09-22
US20110229911A1
Physics

AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES

#10 | 2011-05-12
US20110111526A1
Physics

PRO-ENDOTHELIN-1 FOR THE PREDICTION OF IMPAIRED PEAK OXYGEN CONSUMPTION

#11 | 2011-05-12
US20110111525A1
Physics

PRO-ENDOTHELIN-1 LEVELS FOR THE PREDICTION OF RISK OF TACHYARRHYTMIC EVENTS

#12 | 2010-11-11
US20100285493A1
Physics

Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease

#13 | 2010-06-17
US20100151504A1
Physics

Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP

#14 | 2010-06-10
US20100143953A1
Physics

Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients

#15 | 2010-02-25
US20100047835A1
Physics

Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure

#16 | 2010-02-18
US20100041064A1
Physics

Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II

#17 | 2010-02-11
US20100035275A1
Physics

DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM

#18 | 2010-02-04
US20100028921A1
Physics

Risk stratification for acute coronary syndrome by determining copeptin

#19 | 2008-09-04
US20080213746A1
Physics

Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin

#20 | 2006-03-21
US9381032
-

Receptor binding assays and reagent kit for detecting TSH receptor autoantibodies

InventorID:

586738 ⎘